To provide cardiologists, family practitioners, internal medicine physicians, general practitioners, and doctors of osteopathy with up-to-date information on the treatment and management of patients with hypertension.
This activity is designed for cardiologists, family practitioners, internal medicine physicians, general practitioners, and managed care clinical decision makers. No prerequisites required.
The Johns Hopkins University School of Medicine and the University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
- Provide physicians with guidance on the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7).
- Review treatment guidelines and evaluate antihypertensive treatment options.
- Develop a patient management strategy that emphasizes lifestyle modifications accompanied by appropriate drug treatment.
- Evaluate clinical trials to understand the implications of different treatment options and the long-term use of antihypertensive drugs.
- Understand the public health and economic impact of reducing hypertension.
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Tennessee College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award.
This program is approved for 2 hours (0.2 CEUs) and is cosponsored by the University of Tennessee College of Pharmacy, which is approved by the American Council on Pharmacy Education as a provider of continuing pharmaceutical education. A statement of CE credit will be mailed within 4 weeks of successful completion and evaluation of the program. ACPE program #064-000-05-202-H01.
Each participant should claim only those credits that he/she actually spent in the activity.
The estimated time to complete this educational activity: 2 hours.
Release date: June 15, 2005. Expiration date: June 15, 2007.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine, and the University of Tennessee College of Pharmacy names implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
This program is supported by an educational grant from Sankyo Pharma Inc. and Forest Pharmaceuticals, Inc.